Sars Cov Antibody Igg
Lab Reagents
Human IgG antibody Laboratories manufactures the sars cov antibody igg reagents distributed by Genprice. The Sars Cov Antibody Igg reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars products are available in stock. Specificity: Sars Category: Cov Group: Antibody Igg
SARS-CoV Matrix Antibody |
|||
3529-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
|||
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
SARS-CoV Matrix Antibody |
|||
3529-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
|||
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
SARS-CoV Envelope Antibody |
|||
3533-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
|||
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Envelope Antibody |
|||
3533-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
|||
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV-2 Nucleoprotein IgG Antibody ELISA Kit |
|||
E4821-100 | Biovision | 96 assays | EUR 1057 |
SARS-CoV-2 IgG ELISA Kit 1-plate |
|||
K075-H1R | Arbor Assays | 1-plate | EUR 552 |
Description: This K075-H1R SARS-CoV-2 IgG ELISA Kit 1-plate is only for Research Use Only (RUO), and is not to be used for diagnostic applications. |
SARS-CoV-2 IgG ELISA Kit 5-plate |
|||
K075-H5R | Arbor Assays | 5-plate | EUR 2054 |
Description: This K075-H5R SARS-CoV-2 IgG ELISA Kit 5-plate is only for Research Use Only (RUO), and is not to be used for diagnostic applications. |
SARS-CoV spike protein Antibody |
|||
abx023139-100ug | Abbexa | 100 ug | EUR 857 |
|
SARS-CoV spike protein Antibody |
|||
abx023143-100ug | Abbexa | 100 ug | EUR 857 |
|
Anti-SARS-CoV-2 Antibody |
|||
A2061-50 | Biovision | 50 µg | EUR 480 |
SARS CoV E Protein |
|||
abx060650-1mg | Abbexa | 1 mg | EUR 1692 |
|
SARS CoV Nucleocapsid Protein |
|||
abx060652-1mg | Abbexa | 1 mg | EUR 1873 |
|
SARS-CoV Nucleocapsid Protein |
|||
abx060653-1mg | Abbexa | 1 mg | EUR 1692 |
|
SARS-CoV Nucleocapsid Protein |
|||
abx060654-1mg | Abbexa | 1 mg | EUR 1692 |
|
SARS-CoV Spike Protein |
|||
abx060655-1mg | Abbexa | 1 mg | EUR 1692 |
|
SARS-CoV-2 IgG ELISA Kit 1-plate EUA |
|||
K075-H1 | Arbor Assays | 1-plate | EUR 552 |
Description: This K075-H1 SARS-CoV-2 IgG ELISA Kit 1-plate EUA is only for certified clinical lab use only. The assay has been submitted for Emergency Use Authorization (EUA) through the US FDA. It has not been approved at the current time. |
SARS-CoV-2 IgG ELISA Kit 5-plate EUA |
|||
K075-H5 | Arbor Assays | 5-plate | EUR 2054 |
Description: This K075-H5 SARS-CoV-2 IgG ELISA Kit 5-plate EUA is only for certified clinical lab use only. The assay has been submitted for Emergency Use Authorization (EUA) through the US FDA. It has not been approved at the current time. |